Relations between bone status and glucose metabolism with progression of insulin resistance;A progrediáló inzulinrezisztencia hatása a glükózanyagcsere csontállapot kapcsolatokra

Orvosi Hetilap

Volumn 148, Issue 24, 2007, Pages 1127-1133

  Buday, Barbara ^a,b   Horváth, Tünde ^a   Kulcsár, Eniko ^a   Salamon, Csaba ^c   Literáti Nagy, Botond ^d   Barta, Kitty ^d   Vitai, Márta ^a   Józsa, Rita ^a   Vecsei, Istvánné ^a   Bezzegh, Katalin ^a   Kiss, József ^e   Péterfai, Éva ^a   Koltay, Lászlo ^f   Korányi, László ^a,g  

^a DRC Kft   (Hungary)

^b Peterfy Sandor Utcai Korhaz   (Hungary)

^c Osteoporosis Rendelés   (Hungary)

^d UNIVERSITY OF DEBRECEN   (Hungary)

^e Allami Szívkórház   (Hungary)

^f UNIVERSITY OF PANNONIA   (Hungary)

^g NONE   (Hungary)

Author keywords

Adiponectin; Bone density; Hyperinsulinemic euglycemic clamp; Insulin resistance; Leptin perimenopausa

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; CYTOKINE; GLUCOSE; INSULIN; ADIPONECTIN, HUMAN; BIOLOGICAL MARKER; LEPTIN; RESISTIN; UNCLASSIFIED DRUG;

ADULT; BONE DENSITY; BONE METABOLISM; CLIMACTERIUM; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; EPIDEMIC; FEMALE; FEMUR NECK; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; GLYCEMIC CONTROL; GOLD STANDARD; HIGH RISK PATIENT; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LUMBAR SPINE; MAJOR CLINICAL STUDY; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OSTEOLYSIS; OSTEOPOROSIS; PREVALENCE; PROTEIN BLOOD LEVEL; REVIEW; ARTICLE; BLOOD; BODY MASS; BONE; GLUCOSE BLOOD LEVEL; LUMBAR VERTEBRA; METABOLISM; MIDDLE AGED; RADIODENSITOMETRY;

ADIPONECTIN; ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; BONE AND BONES; BONE DENSITY; DENSITOMETRY, X-RAY; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN; INSULIN RESISTANCE; LEPTIN; LUMBAR VERTEBRAE; MIDDLE AGED; OBESITY; OSTEOPOROSIS; PERIMENOPAUSE; RESISTIN;

EID: 34547689756     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2007.28072     Document Type: Review

References (30)

1. Zimmerman, S. I., Girman, C. J., Buie, V. C. és mtsai: The prevalence of osteoporosis in nursing home residents. Osteoporos. Int., 1999, 9, 151-157.
2. Schmermund, A., Mohlenkamp, S., Erbel, R.: Coronary artery calcium and its relationship to coronary artery disease. Cardiol. Clin., 2003, 21, 521-534.
3. Hak, A. E., Pols, H. A., van Hemert, A. M. és mtsai: Progression of aortic calcification is associated with metacarpal bone loss during menopause: a population-based longitudinal study. Atherioscler. Thromb. Vasc. Biol., 2000, 20, 1926-1931.
4. Marcovitz, P. A., Franklin, B. A., O'Neill, W. W. és mtsa: Usefulness of Bone Mineral Density to predict significant coronary artery disease. Am. J. Cardiol., 2005, 96, 1059-1063.
5. Tuominen, J. T., Impivaara, O., Puukka, P. és mtsai: Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care, 1999, 22, 1196-1200.
6. Sert, M., Tetiker, T., Kirim, S. és mtsai: Type 2 diabetes mellitus and osteopenia: is there an association? Acta Diabetol., 2003, 40, 105-108.
7. van Daele, P. L., Stolk, R. P., Burger, H. és mtsai: Bone density in non-insulin-dependent diabetes mellitus. The Rotterdam Study. Ann. Intern. Med., 1995, 122, 409-414.
8. de Liefde, I. I., van der Klift, M., de Laet, C. E. és mtsai: Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study. Osteoporos. Int., 2005, 16, 1713-1720.
9. ADA expert committee on the diagnosis and classification of diabetes mellitus. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care, 1997, 20, 1183-1197.
10. DeFronzo, R. A, Tobin, J. D, Andres, R.: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol., 1979, 237, E214-E223
11. Matthews, D. R., Hosker, J. P., Rudensky, A. S. és mtsai: Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 1985, 28, 312-319.
12. Diabetes Trial Unit. The Oxford Centre for Diabetes, Endocrinology & Metabolism., Churcill Hospital, Old Road, Headington, Oxford OX3 7LJ, UK. www.dtu.ox.ac.uk/homa/FAQ.html
13. Miller, A. J.: Subset selection in regression. Monographs on Statistics and Applied Probability, 40. London: Chapman and Hall, 1990.
14. Yoon, K. H, Lee, J. H, Kim, J. W., és mtsai: Epidemic obesity and type 2 diabetes in Asia. Lancet, 2006, 368 (9548), 1681-1688.
15. Cooper, C., Melton, L. J.: Magnitude and impact of osteoporisis and fractures. In: Marcus, R., Feldman, D., Kelsey, J. (eds) Osteoporosis. Academic Press, San Diego. 3rd ed. 1996, 419-434.
16. Schwartz, A. V.: Diabetes mellitus: Does it affect bone? Calcif Tissue Int., 2003, 73, 515-519.
17. Leidig-Bruckner, G., Ziegler, R.: Diabetes mellitus - a risk for osteoporosis? Exp. Clin. Endocrinol. Diabetes, 2001, 109 (Suppl. 2), S493-514.
18. Basaria, S.: Link between diabetes and osteoporosis. Diabetes Care, 2000, 23, 564-565.
19. Luo, X. H, Guo, L. J., Yuan, L. Q. és mtsai: Adiponectin stimulates human osteoblasts proliferation and differentiation via MAPK signaling pathway. Exp. Cell. Res., 2005, 309, 99-109.
20. Oshima, K., Nampei, A., Matsuda, M. és mtsai: Adiponectin increases bone mass by suppressing ostoclast and activating osteoblast. Biochem. Biophys. Res. Commun., 2005, 33, 520-526.
21. Froesch, E. R, Schmid, C., Schwander, J. és mtsai: Actions of insulin-like growth factors. Annu. Rev. Physiol., 1985, 47, 443-467.
22. Dagogo-Jack, S., al-Ali, N., Qurttom, M.: Augmentation of bone mineral density in hirsute women. J. Clin. Endocrinol. Metab., 1997, 82, 2821-2825.
23. Di Carlo, C., Shoham, Z., MacDougall, J. és mtsai: Polycystic ovaries as a relative protective factor for bone mineral loss in young women with amenorrhea. Fertil Steril, 1992, 57, 314-319.
24. Koranyi L., Bourey, R., Turk, J. és mtsai: Differential expression of rat pancreatic islet Beta-cell glucose transporter (GLUT2), proinsulin and islet amyloid polypeptide genes after prolonged fasting, insulin-induced hypoglycaemia and dexamethasone treatment. Diabetologia, 1992, 35, 1125-1130.
25. Bronsky, J., Prusa, R., Nevoral, J.: The role of amylin and related peptides in osteoporosis. Clin. Chem. Acta, 2006, 373, 9-16.
26. Thomas, D. M., Ng, K. W, Best, J. D.: Insulin and bone: a clinical and scientific review. Endocrinol. Metab., 1997, 4, 5-17.
27. Ibánez, L., Valls, C., Ong, K. és mtsai: Metformin therapy during puberty delays menarche, prolongs pubertal growth, and augments adult height: A randomized study in Low-Birth-Weight Girls with early-normal onset of puberty. J. Clin. Endocrinol. Metab., 2006, 91, 2068-2073.
28. Soroceanu, M. A., Miao, D., Bai, X. Y. és mtsai: Rosiglitazone impacts negatively on bone by promoting osteoblast/ osteocyte apoptosis. J. Endocrinol., 2004, 183, 203-216.
29. Taniguchi, C. M., Emanuelli, B., Kahn, C. R.: Critical nodes in signaling pathways: insights into insulin action. Nat. Rev. Mol. Cell Biol., 2006, 7, 85-96.
30. Botolin, S., McCabe, L. R.: Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways: J Cell Biochem., 2006, 99, 411-424.